Kirstin A Zettlitz

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Pluripotent Stem Cells

Structure Activity Relationship

Positron Emission Tomography

Top Venues

Molecular cancer therapeutics

Chemical science

European journal of nuclear medicine and molecular imaging

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics 23 (6) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics 23 (6) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics 23 (6) (2024)
Ann M Chan, Tove Olafsen, Jessica Tsui, Felix B Salazar, Brian Aguirre, Kirstin A Zettlitz, Michael Condro, Anna M Wu, Jonathan G Braun, Lynn K Gordon, Negin Ashki, Julian P Whitelegge, Shili Xu, Oluwatayo Ikotun, Jason Thanh Lee, Madhuri Wadehra
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Molecular cancer therapeutics (2024)
Kirstin A Zettlitz, Felix B Salazar, Reiko E Yamada, K Ryan Trinh, Alex Vasuthasawat, John M Timmerman, Sherie L Morrison, Anna M Wu
89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model. Molecular cancer therapeutics 21 (4) (2022)
Kirstin A Zettlitz, Wen-Ting K Tsai, Scott M Knowles, Felix B Salazar, Naoko Kobayashi, Robert E Reiter, Anna M Wu
[89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model. Molecular imaging and biology 22 (2) (2021)
Raymond F Gamache, Kirstin A Zettlitz, Wen-Ting K Tsai, Jeffrey Collins, Anna M Wu, Jennifer M Murphy
Tri-functional platform for construction of modular antibody fragments for in vivo 18F-PET or NIRF molecular imaging. Chemical science 11 (7) (2020)
Hee-Kwon Kim, Muhammad Rashed Javed, Supin Chen, Kirstin A Zettlitz, Jeffrey Collins, Anna M Wu, Chang-Jin C J Kim, R Michael van Dam, Pei Yuin Keng
On-demand radiosynthesis of N -succinimidyl-4-[ 18 F]fluorobenzoate ([ 18 F]SFB) on an electrowetting-on-dielectric microfluidic chip for 18 F-labeling of protein. RSC advances 9 (55) (2019)
Kirstin A Zettlitz, Richard Tavaré, Wen-Ting K Tsai, Reiko E Yamada, Noel S Ha, Jeffrey Collins, R Michael van Dam, John M Timmerman, Anna M Wu
18F-labeled anti-human CD20 cys-diabody for same-day immunoPET in a model of aggressive B cell lymphoma in human CD20 transgenic mice. European journal of nuclear medicine and molecular imaging 46 (2) (2018)
Fabian Richter, Kirstin A Zettlitz, Oliver Seifert, Andreas Herrmann, Peter Scheurich, Klaus Pfizenmaier, Roland E Kontermann
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity. mAbs 11 (1) (2018)
Mo Zhang, Naoko Kobayashi, Kirstin A Zettlitz, Evelyn A Kono, Joyce M Yamashiro, Wen-Ting K Tsai, Ziyue K Jiang, Chau P Tran, Chung Wang, Johnny Guan, Anna M Wu, Robert E Reiter
Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (1) (2018)